Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes. 2004

Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Transforming growth factor-beta (TGF-beta) induces apoptosis in fetal rat hepatocytes. However, a subpopulation of these cells survives concomitant with changes in morphology and phenotype, reminiscent of an epithelial mesenchymal transition (EMT) [Exp. Cell Res. 252 (1999) 281-291]. In this work, we have isolated the subpopulation that survives to TGF-beta-induced apoptosis, showing that these cells maintain the response to TGF-beta in terms of Smads activation and growth inhibition. Analyses of the intracellular signals that could impair the apoptotic effects of TGF-beta have indicated that the phosphatidylinositol 3-kinase (PI 3-K)/Akt pathway is activated in these resistant cells. Experiments in fetal rat hepatocytes have shown that TGF-beta is able to transiently activate PI 3-K/Akt by a mechanism independent of protein synthesis but dependent on a tyrosine kinase activity. Pro-apoptotic signals, such as oxidative stress and caspases, contribute to the loss of Akt at later times. Inhibiting PI 3-K sensitizes fetal hepatocytes (FH) to the apoptosis induced by TGF-beta and causes spontaneous death in the resistant cells. In conclusion, TGF-beta, as it is known for other cytokines, could be inducing pro-apoptotic and survival signals in hepatocytes, the balance among them will decide cell fate.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females

Related Publications

Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
November 2002, Molecular cancer research : MCR,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
October 1992, FEBS letters,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
July 1991, The Journal of biological chemistry,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
November 1995, Journal of cellular physiology,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
June 1996, Journal of cellular physiology,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
June 1995, Toxicology and applied pharmacology,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
September 2000, Hepatology (Baltimore, Md.),
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
May 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
January 2004, Free radical biology & medicine,
Francisco Valdés, and Miguel M Murillo, and Angela M Valverde, and Blanca Herrera, and Aránzazu Sánchez, and Manuel Benito, and Margarita Fernández, and Isabel Fabregat
March 1996, Journal of cellular physiology,
Copied contents to your clipboard!